Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Claessens

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
European Journal of Nuclear Medicine|November 1, 1996
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infectionC J van der Laken, O C Boerman, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibodyL F Massuger, P Kenemans, R A Claessens, et al.
European Journal of Nuclear Medicine|November 1, 1995
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental modelC J van der Laken, O C Boerman, W J Oyen, et al.
Nuclear Medicine Communications|July 1, 1991
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancerL F Massuger, R A Claessens, P Kenemans, et al.
Journal of the National Cancer Institute|June 16, 1993
Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2J G Tibben, O C Boerman, R A Claessens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin GW J Oyen, P M Netten, J A Lemmens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1996
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomesW J Oyen, O C Boerman, G Storm, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
European Journal of Nuclear Medicine|November 1, 1996
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infectionC J van der Laken, O C Boerman, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibodyL F Massuger, P Kenemans, R A Claessens, et al.
European Journal of Nuclear Medicine|November 1, 1995
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental modelC J van der Laken, O C Boerman, W J Oyen, et al.
Nuclear Medicine Communications|July 1, 1991
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancerL F Massuger, R A Claessens, P Kenemans, et al.
Journal of the National Cancer Institute|June 16, 1993
Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2J G Tibben, O C Boerman, R A Claessens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin GW J Oyen, P M Netten, J A Lemmens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1996
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomesW J Oyen, O C Boerman, G Storm, et al.
Pageof 5